Portfolio company
Latigo
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This clinical-stage biopharmaceutical company develops non-opioid medicines to treat acute and chronic pain for patients needing alternatives to addictive painkillers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Latigo Biotherapeutics
This clinical-stage biopharmaceutical company develops non-opioid medicines to treat patients suffering from pain without the risk of addiction.
Mimetic Medicines
This company develops non-opioid peptide drug candidates for patients suffering from chronic pain.
Dolinnov
This biotechnology company develops non-opioid RNA therapies for patients suffering from severe chronic pain, including cancer and neuropathic conditions.
Epiodyne
This biotechnology company develops small-molecule opioid medicines for patients requiring pain management or treatment for opioid use disorder.
PainReform
This pharmaceutical company develops extended-release anesthetic formulations to provide post-operative pain relief for surgical patients and reduce opioid dependency.
Brise Pharmaceuticals Co., LTD.
This biopharmaceutical company develops analgesic treatments for patients with severe pain conditions including migraine, neuropathic pain, and musculoskeletal pain.
Centrexion Therapeutics
This biopharmaceutical company develops non-opioid and non-addictive therapies for patients with chronic pain conditions like osteoarthritis and diabetic neuropathy.
Brixton Biosciences
This life sciences company develops a nerve-selective injectable biomaterial that provides long-lasting, drug-free pain relief for patients suffering from chronic and acute orthopedic conditions.
